Login
Search Website
Menu
Home
About Us
Who We Are
CSCC Governance
CSCC By-Laws
Our History
CSCC Awards & Grants
Join CSCC
Provincial Sections
Alberta (ASCC)
Ontario (OSCC)
Academy
CACB Board of Directors
CACB Awards
Training
Certification & Fellowship
Maintenance of Competence
Meeting Accreditation
Education & Scientific Affairs
Clinical Biochemistry Journal
The Lab Report Podcast
Library & Other Resources
Leadership in Quality Management Course
Join CSCC Listserv
CliCK Study Tool
Interest Groups & Committees
CALIPER SIG
COVID-19 SIG (Inactive)
Monoclonal Gammopathy SIG
Pediatric & Perinatal SIG
Point of Care Testing SIG
Quality Indicators SIG
Toxicology SIG
Utilization Management SIG
Harmonization of Reference Intervals Working Group
Quality Management Working Group
Educating the Public on Clinical Chemistry (EPOCC) Committee
Archives Committee
CSCC Practice Guidelines, Position Statements & Reports
NIH LDL-c Equation Tool Kit
News & Events
CSCC Annual Conference
Conference Archives
Non-Member Certificates
CSCC Events
2024-2025 Education Roundtable Series
2024-2025 Education Roundtable Registration
2024 CSCC Travelling Lectureship
Town Hall
Industry Webinars
Quidel Ortho Webinar
Regulated Profession and Advocacy
News
Contact Us
Speaker
Information Form, OSCC ASM, October 10-11, 2024
OSCC Home
OSCC About Us
OSCC Membership & By-Laws
OSCC Awards
OSCC Events
OSCC AGM
OSCC Listserv
OSCC Newsletters
OSCC Presentations
Speaker Information Form, OSCC ASM, October 10-11, 2024
Email
If you would like to receive a copy of this submission to your email, please enter it here.
Your Session Information
Title of Presentation
(Required)
First Name
(Required)
Last Name
(Required)
Position
(Required)
Institution/Company
(Required)
Information Required for Accreditation Purposes
1. Overview
(Required)
Brief statement of presentation. Sample: "This lecture will describe the chemical and biological role of Maillard reaction and formation of advanced glycation end products in aging and age-related diseases such as diabetes, end stage renal disease and cataracts. New therapies designed to prevent the impact of glycation in these diseases will be discussed."
50 to 120 words
2. Intended Audience Level
(Required)
Basic
Intermediate
Advanced
3. Learning Objectives and Outcomes
(Required)
State the education objectives for your activity. What will learners be able to do after the activity that they could not do before? Statement must begin with “At the conclusion of this session, participants will be able to …” SAMPLE: Pediatric Poisonings - At the conclusion of this session, participants will be able to: 1) Appreciate the limitations of routine drug screens in identifying overdose in infants and children. 2) Understand the need and use of Advanced Technology for overdoses in the Pediatric Population. 3) Appreciate the importance of interaction with Clinical Staff for correct interpretation. STATE AT LEAST 2 LEARNING OBJECTIVES.
At the conclusion of this session, participants will be able to: 1)
Biographical Information
Upload Brief Biography of Approximately 150-200 Words, For Introduction Purposes
(Required)
Max. file size: 30 MB.
Electronic Copy of a Recent Head & Shoulders Photograph
(Required)
Max. file size: 30 MB.
Authors Copyright Declaration
Declaration
(Required)
I, the author of this presentation, certify that I have obtained all customary and necessary permission to use and print any copyright material that appears in my presentation. I agree that the Ontario Society of Clinical Chemists may make my presentation available to individuals who may be interested in accessing it by posting it on the OSCC website.
I agree to the above
Date
(Required)
MM slash DD slash YYYY
Conflict of Interest Disclosure
A conflict of interest occurs when the financial interests of a speaker/author potentially preclude an unbiased, scientific presentation of a subject. The reason for requesting disclosure of possible conflict of interest is not to censor or exclude speakers, but to inform the audience so they may decide for themselves whether or not a presentation is biased. Information from this declaration will be disclosed to participants as follows: “Dr. Jones has research support from XYZ instruments,” but will not be used to exclude speakers from a program.
All speakers must complete this form.
All speakers in accredited Continuing Education Programs must disclose any possible conflict of interest
regarding the topic that is being presented
. A conflict of interest is defined as
any financial interest of the speaker in a company's products or services discussed in the presentation
. For example, if the speaker
(1) holds stock
in the company,
(2) is paid salary or consultant fees
by the company,
(3) has grant support
from the company, and/or
(4) has received support for travel expenses, honoraria, etc.
, from the company, a conflict of interest exists regarding this topic and must be reported. If the speaker has a financial interest in a company but is not discussing a product or service of that company, no conflict of interest must be disclosed.
I have read the above statements and (please select the appropriate choice and sign below).
(Required)
I declare that neither I nor any member of my immediate family has a financial interest in a company as defined in the CSCC/OSCC policies on conflict of interest
I (or a member of my immediate family) has a financial interest in a company as defined in the CSCC/OSCC policies on conflict of interest (specify below).
Name
First
Last
First Name
(Required)
Last Name
(Required)
Signature
(Required)
Date
MM slash DD slash YYYY
Financial Interest Disclosure
1. Grant/Research Support
2. Salary/Consultant Fee
3. Stocks/Bonds
4. Honorarium/Expenses
List company/companies:
Failure to disclose, or false disclosure, will require the Planning Committee to identify a replacement speaker.